SGLT2 inhibitors as the bedrock of therapy for heart failure
- PMID: 36041473
- DOI: 10.1016/S0140-6736(22)01584-7
SGLT2 inhibitors as the bedrock of therapy for heart failure
Comment on
-
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.Lancet. 2022 Sep 3;400(10354):757-767. doi: 10.1016/S0140-6736(22)01429-5. Epub 2022 Aug 27. Lancet. 2022. PMID: 36041474
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical